Bellerophon Therapeutics Inc expected to post a loss of 48 cents a share - Earnings Preview

Bellerophon Therapeutics

27/03/2023 22:59

* Bellerophon Therapeutics Inc  BLPH.OQ   BLPH.O  is
expected
to show no change in quarterly revenue when it reports 
results on March 29 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Bellerophon
Therapeutics
Inc is for a loss of 48 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Bellerophon
Therapeutics Inc is $24.5​, above​ its last closing price
of $7.64. ​​​

This summary was machine generated March 27 at 21:59 GMT.  All
figures in US dollars  unless otherwise stated